Detlef Schumann

Detlef Schumann Email and Phone Number

Corporate Executive @ CeGaT GmbH
Detlef Schumann's Location
Reutlingen, Baden-Württemberg, Germany, Germany
Detlef Schumann's Contact Details

Detlef Schumann personal email

n/a
About Detlef Schumann

Ask people who know me well and I believe they would talk about my expertise in cell & gene therapy, biotechnology, pharma, ATMPs and medical decvices.I hope they would mention my strong experience in establishing global strategic alliances and partnerships, due diligence, and mergers & acquisitions in the EU and Middle East , Asia Pacific, Japan, Singapore and USA regions. My successes in these area have come in the pharmaceutical and medical device industry. I excel at designing and implementing processes and procedures that improve operational efficiencies. My extensive background includes developing and overseeing personnel who equal and surpass objectives and standards. Plus, I have a strong ability to manage projects from concept to completion ensuring on-time, on-budget, and on-target delivery.

Detlef Schumann's Current Company Details
CeGaT GmbH

Cegat Gmbh

View
Corporate Executive
Detlef Schumann Work Experience Details
  • Cegat Gmbh
    Managing Director
    Cegat Gmbh Apr 2021 - Present
    Tübingen, Baden-Württemberg, De
    Serve on board and executive committee representing B. Braun. Anticipate additional growth expected with stronger cooperation between CEGAT and BBRaun. Supervise 150 personnel.● Created and executed alignment plan for CEGAT-B. Braun seeking future growth by optimizing synergies between both companies (sales, product and service development, etc.). Personalized genetic diagnostics
    View
  • Tetec Tissue Engineering Technologies Ag
    Chief Executive Officer
    Tetec Tissue Engineering Technologies Ag Sep 2020 - Present
    Reutlingen - Kusterdingen, Baden-Württemberg, De
    Prepare and execute new business strategy aimed and reversing underperforming company. Introduce contract manufacturing services for pharma and biotech. Maximize enterprise structure and organizational development. Transform manual towards automated cell manufacturing. Lead global biological strategy roadmap across B. Braun. Oversee daily biological activities for European and Asian (Japan and China) expansion. Determine marketing and business development structure. Supervise 140 staff.● Developed and implemented tactics to accelerate EMA registration and commercial expansion into high price markets.● Negotiated new CMO deal spurring 25% growth.
    View
  • Bbraun Aesculap
    Vice President Front End Innovation & Materials & Sterile Technology
    Bbraun Aesculap May 2018 - Sep 2020
    Managed setup and implementation of strategic partnerships. Revamped and guided laboratory structure and organization. Served on global sterile goods management lead team developing and executing global strategic business roadmaps. Built and arranged virtual biologics expertise cluster (AIC USA, COE Rubi, TETEC, and Aesculap). Supported mergers and acquisitions and technological reviews. Liaised with private public partnership programs and expertise networks. Led 78-person team.● Created next generation product pipeline of Aesculap ranging from market leading sterile container systems up to Augmented Reality Systems and disruptive infection prevention products.
  • Dsm Biomedical
    New Business Development Manager I Regenerative Materials
    Dsm Biomedical May 2013 - May 2018
    Spearheaded EMEA/AP business development for regenerative medicine division. Extended market development for EMEA and AP. Contacted and secured new customers and strategic partnerships. Negotiated and administrated agreements. Created and introduced EMEA/AP regenerative medicine business and marketing campaigns including product launches. Partnered with clinicians on clinical strategy and relationship management. ● Opened and expanded regenerative and overall product and services into EMEA and AP (latter strong focus on Japan) through 180+ contracts and multiple strong strategic alliances with multinational businesses.● Continued growth of Japanese Market for total DSM Biomedical started in 2015 with strategy development for all therapeutic markets followed by strategy implementation aimed at business development, strategic alliances, and regulatory/reimbursement.
  • Dsm Biomedical
    R&D Program Manager
    Dsm Biomedical Feb 2008 - May 2013
    Helmed research initiatives in orthopaedics/trauma, drug delivery, and biomaterial development. Delivered AD and MSK/Pain Drug tactics. Formed global partnerships with academic and clinical enterprises. Prepared and led in-vitro and in-vivo studies for biomedical applications. Designed and oversaw biocompatibility and biostability studies. Directed private-public partnership programs (e.g. BMM) and various industry contact partner for academic, clinical, and industrial clients. Aided medical device (prototype) design and drug delivery solutions. Served as internal R&D expert for implant solutions and drug delivery marketing and sales.● Participated in multiple due diligence and M&A activities.● Liaised with clinicians and medical device experts to find and invent biomaterial/device and biomaterial/drug methods addressing clinical needs.● Represented company on Dutch and international regenerative medicine committees.
  • Massachusetts Institute Of Technology And Harvard Medical School
    Alexander Von Humboldt Postdoctoral Scholar
    Massachusetts Institute Of Technology And Harvard Medical School Oct 2006 - Dec 2007
    Alexander von Humboldt ScholarPostdoc at MIT and HarvardCenter for biomedical engineering, Massachusetts Institute of Technology, Cambridge, MA, USA andCenter for Genetics and Genomics, Harvard Medical School, Boston, MA, USAInvestigated the influence of mechanobiological load on osteoarthritic (OA) osteochondral explants in a simulated in vivo environment to investigate changes in catabolic or anabolic pathways on the gene and protein level.- Novel knowledge could help in innovative drug design for the treatment of degenerative diseases of the musculoskeletal system (e.g. Osteoarthritis)
  • National University Of Singapore
    Postdoctoral Fellow
    National University Of Singapore Aug 2005 - Sep 2006
    Research Fellow, Department of Orthopaedic Surgery, NUS Tissue Engineering Program, National University of Singapore, Singapore- In vivo study of spinal fusion on large animals (pigs) using stem cells, growth factors and special designed biodegradable FDM made PCL-TCP biocagesResearch Fellow, Division of Bioengineering, National University of Singapore, Singapore- Design of a novel two-stream perfusion bioreactor for one-step tissue engineering of osteochondral tissue with stem cells and a novel multicompartment biomaterial- Biomaterial design using electrospinning (Collagen (I and II), PCL and HYAFF nanofibers) and FDM techniques (PCL-TCP)- Bone Tissue Engineering
  • University Hospital Regensburg / Trauma Surgery
    Postdoctoral Position
    University Hospital Regensburg / Trauma Surgery Apr 2004 - Aug 2005
    Department for Experimental Trauma Surgery (University Hospital Regensburg, Germany)- Design of research plans for osteochondral tissue repair- Performing of human stem cell based tissue engineering experiments- Development of new bioreactors for mechanobiology- Manufacturing of improved tissue engineering scaffolds- Congress organization
  • Competence Center For Medical Biotechnology (Biopark, Regensburg)
    Coordinator/Management
    Competence Center For Medical Biotechnology (Biopark, Regensburg) Apr 2004 - Aug 2005
    - Management of architectural, financial and inventory aspects- Responsible for business affairs- Did business plan writing for start up company- Organised transfer of six research units from different departments into the center- Public relation management
  • University Of Regensburg
    Phd Fellow
    University Of Regensburg Sep 2000 - Apr 2004
    Bavaria, De
    Department for Experimental Trauma Surgery (University Hospital Regensburg, Germany)Department of Pharmaceutical Technology (University of Regensburg, Germany)- Instructed and supervised the lab personal and medical undergraduate/graduate students studying for a doctorate- Did Tissue Engineering of cartilage with human mesenchymal stem cells (MSC)- Investigated mechanobiological influences on human stem cell differentiation- Developed new methods for in vivo angiogenesis research For experimental design and methods see chapter “education”- Wrote and defended patents for a newly developed hyaluronan-gelatine composite scaffold
    View
  • Bristol Myers Squibb/Pmr
    Pharmaceutical Intern - Project Leader
    Bristol Myers Squibb/Pmr Nov 1999 - Apr 2000
    - Managed GMP and GLP affairs in the Quality Control- Manufactured cytostatics and other drugs under sterile conditions- Developed and validated new analytical methods- Did all kinds of modern analytical methods (HPLC, GC, IR, UV-VIS, TLC etc.)- Project and Team Leader
  • Thurn Und Taxis Pharmacy
    Pharmaceutical Intern
    Thurn Und Taxis Pharmacy May 1999 - Nov 1999
    - Manufactured drugs- Supervised and performed drug control and storage- Advised customers- Managed economic affairs
  • Bristol-Myers Squibb
    Several Internships
    Bristol-Myers Squibb Jan 1991 - Sep 1998
    Lawrence Township, Nj, Us
    Department for Regulatory Affairs (Bristol-Myers Squibb Company, Regensburg) - Developed chemical – and pharmaceutical documentations to obtain the registration of finished products- Created analytical documentations for Germany, USA and other export countries- Performed expert correspondence with pharmacies, hospitals, universities and authorities; correspondence, both oral and written with BMS USA- Assisted handling of BfArM – inquiries for drugs which have to be reregistrated in germany
    View

Detlef Schumann Skills

Cell Biomedical Engineering Drug Delivery Medical Devices Bone R&d Tissue Engineering Biomaterials Lifesciences Regenerative Medicine Program Management Pharmacy Life Sciences Cell Culture Iso 10993 Musculoskeletal Cartilage Molecular Biology Polymers Cell Biology Tissue Culture Biotechnology Clinical Development Research Product Development Materials Healthcare Cross Functional Team Leadership Materials Science Imaging Clinical Trials Science Quality Systems Stem Cells Biocompatibility Biopolymers Angiogenesis Bioengineering Gene Expression Profiling Cell Therapy Rt Pcr Animal Handling Cell Based Assays Immunohistochemistry Animal Models Spine Pain Osteoarthritis Start Ups Elisa

Detlef Schumann Education Details

  • University Of Regensburg
    University Of Regensburg
    Regenerative Medicine / Pharmaceutical Technology
  • University Of Regensburg
    University Of Regensburg
    Pharmacy

Frequently Asked Questions about Detlef Schumann

What company does Detlef Schumann work for?

Detlef Schumann works for Cegat Gmbh

What is Detlef Schumann's role at the current company?

Detlef Schumann's current role is Corporate Executive.

What is Detlef Schumann's email address?

Detlef Schumann's email address is de****@****egat.de

What schools did Detlef Schumann attend?

Detlef Schumann attended University Of Regensburg, University Of Regensburg.

What skills is Detlef Schumann known for?

Detlef Schumann has skills like Cell, Biomedical Engineering, Drug Delivery, Medical Devices, Bone, R&d, Tissue Engineering, Biomaterials, Lifesciences, Regenerative Medicine, Program Management, Pharmacy.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.